R

Regenlab USA Inc.

RGNAFiled

Regenlab USA Inc. · Nasdaq · Research source · S-1 · 2026-09-25 · Latest filing · S-1/A · 2026-10-27 SEC ↗

Report source
Research source · S-1 · 2026-09-25
SummaryBASIC RESEARCHReport source · S-1

Preliminary S-1 leaves core IPO terms incomplete despite established regenerative-medicine operations.

As of the September 25, 2026 S-1, RegenLab’s IPO price, share count and proceeds remain placeholders, while Nasdaq listing is unapproved.

Ownership and votingAntonino Turzi98.64% economic · Awaiting verification voting
Next disclosed checkpointSEC effectiveness and completion of final offering terms; no confirmed closing or trading date is supplied.S-1 · 2026-09-25
Business and development direction

Regenlab USA Inc.

Current business
Future development
DECISION DRIVERS

Key risks

Risk 1

Failure to obtain or maintain CE-MDR, FDA 510(k), PMA or other approvals could delay or prevent commercialization.

Risk 2

Commercialization depends on reimbursement, healthcare-professional relationships, sales-force development and distributors.

Risk 3

The company reports operating losses, negative operating cash flow, substantial indebtedness, working-capital deficit and a going-concern reference.

Next checkSEC effectiveness and completion of final offering terms; no confirmed closing or trading date is supplied.
Latest filing2026-10-27
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Offering qualitySource-linked structured inputs are not yet available. Open filing ↗
BOOKRUNNERS / LEAD UNDERWRITERSUnderwriters named in the prospectus
PRELIMINARY
#InstitutionUnderwriting allocationRatioShares
1StoneX Financial Inc.
Source and calculation

Names are explicitly identified in source underwriting tables or role clauses. Quantities require the named firm's own table row; missing allocations are not inferred.

Source · S-1 ↗

IPO CAPITAL QUALITY

Issuer capital
Selling-holder liquidity
Primary shares
Secondary shares
Basis and evidence

S-1 · 2026-09-25

As of the September 25, 2026 S-1, RegenLab’s IPO price, share count and proceeds remain placeholders, while Nasdaq listing is unapproved.

Offering structure

Source and calculation
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Use of proceedsSource-linked structured inputs are not yet available. Open filing ↗

Dilution and valuation

IPO price—
Basic post-offer—
Equity value—

Reported figures remain on their stated basis. Exact compatible price and whole-issuer post-offer inputs are required for calculations.

Dilution and valuation
CalculationSharesValueReference
Pre-offer shares6,238,266—
Reported sourcePre-offersharesBasis and evidence 1 ↗
Basis and evidence ↗
Basis and evidence 1

outstanding before offering

Reported inputs; each row retains its own source basis.

Principal Stockholders ↗

Share-count comparison

Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.

Source ↗
SCENARIO · NOT A FORECAST

IPO valuation scenario simulator

Source inputs required

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Source ↗
Implied equity value—Price × post-offer shares
Post-offer shares—Share count, not tradable float
Existing-holder ownership reduction—Assumes new shares only; secondary sales do not increase shares.
Source and calculation ↗
Security and offer price

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Base post-offer shares

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Equity value

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Share-count change

Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.

Alternative scenarios

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Sensitivity

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Source and calculation

The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.

Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Ownership across stagesSome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
As of
2026-09-25
!Antonino Turzi remains the dominant holder and voting controller; post-offering percentages are blank.View source ↗
Relationship filters
Show
ownership / voting rights
Select for details · Regenlab USA Inc.
Founder / personFund / entityPublic floatShare classEvery relationship is dated and linked to its supporting SEC filing. Percentages marked * are filing-based estimates.

Holdings and voting rights

Holder groups may overlap; these rows are not an additive ownership partition.

Holdings and voting rights
Holder / measureSharesOwnershipVoting rightsReference
Antonino TurziEconomic ownership · Antonino Turzi—98.64%Economic—
beneficial ownership before offeringReport statementEvidence
Antonino TurziBeneficial shares6,153,426——
Shares of CommonBeneficially StockOwnedDisclosedEvidence
Dr. Daphne Metzger, PhDBeneficial shares24,329——
Shares of CommonBeneficially StockOwnedDisclosedEvidence
All directors and executive officers as a group (8 persons)Beneficial shares6,177,755——
Shares of CommonBeneficially StockOwnedDisclosedEvidence
Antonino TurziBeneficial ownership—98.64%Beneficial—
Percent of CommonStock BeneficiallyOwned BeforeOffering(1)DisclosedEvidence
All directors and executive officers as a group (8 persons)Beneficial ownership—99.01%Beneficial—
Percent of CommonStock BeneficiallyOwned BeforeOffering(1)DisclosedEvidence
Mr. Antonino Turzi, our principal stockholder, currentlyVoting power——approximately 98.64%Voting power
Source statement; approximately ; source predicate: controls; primary source clause; full source conditions retained; source scope: of the voting power of our capital stock (based on shares of common stock outstanding as of September 21, 2026) and will control approximately [___]% of the combined voting power of our capital stock; not an additive ownership partitionDisclosedEvidence
Antonino Turzi, our principal stockholderVoting power——approximately 98.5%Voting power
Source statement; approximately ; source predicate: controls; primary source clause; full source conditions retained; source scope: of the voting power of our capital stock (based on shares of common stock outstanding as of December 31, 2025) and will control approximately [___]% of the combined voting power of our capital stock; not an additive ownership partitionDisclosedEvidence
our FounderOwnership as disclosed—>50%Beneficial—
Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding shares of common stock, which will cause us to be deemed a “controlled company” under the rules of Nasdaq; not an additive ownership partitionDisclosedEvidence
our FounderVoting power——approximately 98.64%Voting power
Source statement; approximately ; source predicate: controls; primary source clause; full source conditions retained; source scope: of the voting power of our capital stock and will control approximately [___]% of the combined voting power of our capital stock upon completion of this offering; not an additive ownership partitionDisclosedEvidence
Mr. TurziOwnership as disclosed—>50%Beneficial—
Source statement; >; source predicate: owns; primary source clause; full source conditions retained; source scope: of our outstanding shares (and will continue to own more than; not an additive ownership partitionDisclosedEvidence
Source and calculation ↗
Antonino Turzi · Economic ownership · Antonino Turzi · 98.64%

beneficial ownership before offering

beneficial ownership before offering

0001829126-26-010431 · Principal Stockholders ↗

Antonino Turzi · Antonino Turzi — Beneficial shares · 6,153,426

Exact source ownership column: Shares of CommonBeneficially StockOwned; holders may overlap; not an additive partition

Raw source column: Shares of CommonBeneficially StockOwned; source holder: Antonino Turzi

0001829126-26-010431 · SEC table 427 row 3 columns 4; source 1695480:1713949; SHA256 87ab26707c23eade1b9de15ff295a242074d4857b5195a01ccdd53667e25a350; ownership header cells 1:3 ↗

Dr. Daphne Metzger, PhD · Dr. Daphne Metzger, PhD — Beneficial shares · 24,329

Exact source ownership column: Shares of CommonBeneficially StockOwned; holders may overlap; not an additive partition

Raw source column: Shares of CommonBeneficially StockOwned; source holder: Dr. Daphne Metzger, PhD

0001829126-26-010431 · SEC table 427 row 6 columns 4; source 1695480:1713949; SHA256 87ab26707c23eade1b9de15ff295a242074d4857b5195a01ccdd53667e25a350; ownership header cells 1:3 ↗

All directors and executive officers as a group (8 persons) · All directors and executive officers as a group (8 persons) — Beneficial shares · 6,177,755

Exact source ownership column: Shares of CommonBeneficially StockOwned; holders may overlap; not an additive partition

Raw source column: Shares of CommonBeneficially StockOwned; source holder: All directors and executive officers as a group (8 persons)

0001829126-26-010431 · SEC table 427 row 11 columns 4; source 1695480:1713949; SHA256 87ab26707c23eade1b9de15ff295a242074d4857b5195a01ccdd53667e25a350; ownership header cells 1:3 ↗

Antonino Turzi · Antonino Turzi — Beneficial ownership · 98.64%

Exact source ownership column: Percent of CommonStock BeneficiallyOwned BeforeOffering(1); holders may overlap; not an additive partition

Raw source column: Percent of CommonStock BeneficiallyOwned BeforeOffering(1); source holder: Antonino Turzi

0001829126-26-010431 · SEC table 427 row 3 columns 8,9; source 1695480:1713949; SHA256 87ab26707c23eade1b9de15ff295a242074d4857b5195a01ccdd53667e25a350; ownership header cells 1:6 ↗

All directors and executive officers as a group (8 persons) · All directors and executive officers as a group (8 persons) — Beneficial ownership · 99.01%

Exact source ownership column: Percent of CommonStock BeneficiallyOwned BeforeOffering(1); holders may overlap; not an additive partition

Raw source column: Percent of CommonStock BeneficiallyOwned BeforeOffering(1); source holder: All directors and executive officers as a group (8 persons)

0001829126-26-010431 · SEC table 427 row 11 columns 8,9; source 1695480:1713949; SHA256 87ab26707c23eade1b9de15ff295a242074d4857b5195a01ccdd53667e25a350; ownership header cells 1:6 ↗

Mr. Antonino Turzi, our principal stockholder, currently · Mr. Antonino Turzi, our principal stockholder, currently — Voting power · approximately 98.64%

Source statement; approximately ; source predicate: controls; primary source clause; full source conditions retained; source scope: of the voting power of our capital stock (based on shares of common stock outstanding as of September 21, 2026) and will control approximately [___]% of the combined voting power of our capital stock; not an additive ownership partition

Mr. Antonino Turzi, our principal stockholder, currently controls approximately 98.64% of the voting power of our capital stock (based on shares of common stock outstanding as of September 21, 2026) and will control approximately [___]% of the combined voting power of our capital stock upon completion of this offering, and we are therefore a “controlled company” as defined under Nasdaq Marketplace Rules. We do not intend to rely on the controlled company exemptions provided under Nasdaq Marketplace Rules.

0001829126-26-010431 · SEC ownership paragraph; source 24777:25461; SHA256 b35b1707d764828335f9dd6df4882d770e767e32dbcf75940f350662f4fc7112 ↗

Antonino Turzi, our principal stockholder · Antonino Turzi, our principal stockholder — Voting power · approximately 98.5%

Source statement; approximately ; source predicate: controls; primary source clause; full source conditions retained; source scope: of the voting power of our capital stock (based on shares of common stock outstanding as of December 31, 2025) and will control approximately [___]% of the combined voting power of our capital stock; not an additive ownership partition

Antonino Turzi, our principal stockholder, controls approximately 98.5% of the voting power of our capital stock (based on shares of common stock outstanding as of December 31, 2025) and will control approximately [___]% of the combined voting power of our capital stock upon completion of this offering, and we are therefore a “controlled company” as defined under Nasdaq Marketplace Rules. We do not intend to rely on the controlled company exemptions provided under Nasdaq Marketplace Rules.

0001829126-26-010431 · SEC ownership paragraph; source 254882:255540; SHA256 ac595d9088ee7568972c250501396673e302b8928768f4481cd6707f242139bd ↗

our Founder · our Founder — Ownership as disclosed · >50%

Source statement; >; source predicate: beneficially owns; primary source clause; full source conditions retained; source scope: of our outstanding shares of common stock, which will cause us to be deemed a “controlled company” under the rules of Nasdaq; not an additive ownership partition

Antonino Turzi, our Founder, Chairman and CEO, beneficially owns greater than 50% of our outstanding shares of common stock, which will cause us to be deemed a “controlled company” under the rules of Nasdaq.

0001829126-26-010431 · SEC ownership paragraph; source 603467:603881; SHA256 3ce51c6a3a99b593c9766551e00f69a87da9e73b374fa2b6bc2e7c13317ed93c ↗

our Founder · our Founder — Voting power · approximately 98.64%

Source statement; approximately ; source predicate: controls; primary source clause; full source conditions retained; source scope: of the voting power of our capital stock and will control approximately [___]% of the combined voting power of our capital stock upon completion of this offering; not an additive ownership partition

Antonino Turzi, our Founder, Chairman and CEO, currently controls approximately 98.64% of the voting power of our capital stock and will control approximately [___]% of the combined voting power of our capital stock upon completion of this offering. As a result, Mr. Turzi owns more than 50% of our outstanding shares (and will continue to own more than 50% of our outstanding shares upon consummation of the offering), and as such, we are a “controlled company” under the rules of Nasdaq. Under these rules, a company of which more than 50% of the voting power is held by an individual, a group or another company is a “controlled company” and, as such, can elect to be exempt from certain corporate governance requirements, including requirements that:

0001829126-26-010431 · SEC ownership paragraph; source 604051:604998; SHA256 aaf0460be140750d5daaa94ef209e622e4c9ddcc08325f7f7cffd132e489c404 ↗

Mr. Turzi · Mr. Turzi — Ownership as disclosed · >50%

Source statement; >; source predicate: owns; primary source clause; full source conditions retained; source scope: of our outstanding shares (and will continue to own more than; not an additive ownership partition

Antonino Turzi, our Founder, Chairman and CEO, currently controls approximately 98.64% of the voting power of our capital stock and will control approximately [___]% of the combined voting power of our capital stock upon completion of this offering. As a result, Mr. Turzi owns more than 50% of our outstanding shares (and will continue to own more than 50% of our outstanding shares upon consummation of the offering), and as such, we are a “controlled company” under the rules of Nasdaq. Under these rules, a company of which more than 50% of the voting power is held by an individual, a group or another company is a “controlled company” and, as such, can elect to be exempt from certain corporate governance requirements, including requirements that:

0001829126-26-010431 · SEC ownership paragraph; source 604051:604998; SHA256 aaf0460be140750d5daaa94ef209e622e4c9ddcc08325f7f7cffd132e489c404 ↗

Saved control snapshot

The dated saved report retains its own figures and assumptions. These strings are not new calculation inputs.

Saved control snapshot
Holder / measureSharesOwnershipVoting rightsReference
Antonino TurziDisclosed holder—98.64%—
2026-09-25Antonino Turzi remains the dominant holder and voting controller; post-offering percentages are blank.S-1 ↗

Economic ownership

A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.

Share supply

Conditional lock-up duration

Conditional lock-up duration
MeasureReported value
Conditional lock-up duration · executive officers and directorsfollowing closing date; subject to Representative consent180 days
Conditional lock-up duration · all holders of common stock and exercisable or convertible securitiesfollowing effective date of registration statement; subject to Representative consent180 days
Source and calculation
Conditional lock-up duration · executive officers and directors

following closing date; subject to Representative consent

The Offering ↗
Conditional lock-up duration · all holders of common stock and exercisable or convertible securities

following effective date of registration statement; subject to Representative consent

The Offering ↗

Source lock-up conditions

Literal day restriction; anchor not separately resolved; full conditions and exceptions remain in the source paragraph

Source lock-up conditions
MeasureReported value
Our executive officers and directors180 days
Our executive officers and directors180 days
the warrants180 days
our executive officers and directors and holders of all of our common stock180 days
Source and calculation
Our executive officers and directors

Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for 180 days following the closing date of this initial public offering without the prior written consent of the Representative. Any other holders of outstanding shares of our common stock (and all holders of securities exercisable for or convertible into shares of common stock) have also agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for 180 days following the effective date of the registration statement for this offering without the prior written consent of the representative. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”

SEC table 102 row 15; source 265974:277956; SHA256 ed269f84a488be3167ed4f84cc4f7b90776cda442d6c71f0583e9e65ad847452 ↗
Our executive officers and directors

Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for 180 days following the closing date of this initial public offering without the prior written consent of the Representative. Any other holders of outstanding shares of our common stock (and all holders of securities exercisable for or convertible into shares of common stock) have also agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for 180 days following the effective date of the registration statement for this offering without the prior written consent of the representative. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”

SEC lock-up paragraph; source 275318:276256; SHA256 a7ed7e274e2192072f379333cf085fa9c608e462c5f89dd763c01cdbb1c78f30 ↗
the warrants

The Representative’s Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(e)(1)(A) of FINRA. The Representative (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days following the commencement of sales of the securities issued in this offering. In addition, the Representative’s Warrants provide for registration rights upon request, in certain cases. The sole demand registration right provided will not be greater than five years from the commencement of sales of the securities issued in this offering in compliance with FINRA Rule 5110(g)(8)(C). The piggyback registration rights provided will not be greater than seven years from the commencement of sales of the securities issued in this offering in compliance with FINRA Rule 5110(g)(8)(D). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the Representative’s Warrants may be adjusted in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the Representative’s Warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.

SEC lock-up paragraph; source 1842579:1844530; SHA256 9ff5cc592c7480484783e3ec9c286222ed6a00f74b6e0e9a5fd9f6dd2cf2fe51 ↗
our executive officers and directors and holders of all of our common stock

Pursuant to “lock-up” agreements, we, and our executive officers and directors and holders of all of our common stock, have agreed, without the prior written consent of the Representative, not to, directly or indirectly, offer to sell, sell, pledge, or otherwise transfer or dispose of any of shares of (or enter into any transaction or device that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) our common stock, enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of our common stock, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for shares of common stock or any other of our securities or publicly disclose the intention to do any of the foregoing, subject to customary exceptions, for a period of 180 days from the closing date of this offering.

SEC lock-up paragraph; source 1845027:1846270; SHA256 d07068e929e05af3d33d1618ec24f0c6ba48512d44dc1f6bc5599d3e0f7f87ef ↗

Conditional lock-up timeline

Conditional lock-up timeline

Eligibility is not a sale. Release conditions, holder groups and exceptions remain separate.

Milestones and unconfirmed releases

Holder / event
Holder / eventTerm / dateConditions
Our executive officers and directors180 daysOur executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for 180 days following the closing date of this initial public offering without the prior written consent of the Representative. Any other holders of outstanding shares of our common stock (and all holders of securities exercisable for or convertible into shares of common stock) have also agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for 180 days following the effective date of the registration statement for this offering without the prior written consent of the representative. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”
the warrants180 daysThe Representative’s Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(e)(1)(A) of FINRA. The Representative (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days following the commencement of sales of the securities issued in this offering. In addition, the Representative’s Warrants provide for registration rights upon request, in certain cases. The sole demand registration right provided will not be greater than five years from the commencement of sales of the securities issued in this offering in compliance with FINRA Rule 5110(g)(8)(C). The piggyback registration rights provided will not be greater than seven years from the commencement of sales of the securities issued in this offering in compliance with FINRA Rule 5110(g)(8)(D). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the Representative’s Warrants may be adjusted in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the Representative’s Warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.
our executive officers and directors and holders of all of our common stock180 daysPursuant to “lock-up” agreements, we, and our executive officers and directors and holders of all of our common stock, have agreed, without the prior written consent of the Representative, not to, directly or indirectly, offer to sell, sell, pledge, or otherwise transfer or dispose of any of shares of (or enter into any transaction or device that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) our common stock, enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of our common stock, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for shares of common stock or any other of our securities or publicly disclose the intention to do any of the foregoing, subject to customary exceptions, for a period of 180 days from the closing date of this offering.
Basis and evidence
Our executive officers and directors

Our executive officers and directors have agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for 180 days following the closing date of this initial public offering without the prior written consent of the Representative. Any other holders of outstanding shares of our common stock (and all holders of securities exercisable for or convertible into shares of common stock) have also agreed with the underwriters not to sell, transfer or dispose of any shares or similar securities for 180 days following the effective date of the registration statement for this offering without the prior written consent of the representative. For additional information regarding our arrangement with the underwriters, please see “Underwriting.”

SEC lock-up paragraph; source 275318:276256; SHA256 a7ed7e274e2192072f379333cf085fa9c608e462c5f89dd763c01cdbb1c78f30 ↗
the warrants

The Representative’s Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(e)(1)(A) of FINRA. The Representative (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days following the commencement of sales of the securities issued in this offering. In addition, the Representative’s Warrants provide for registration rights upon request, in certain cases. The sole demand registration right provided will not be greater than five years from the commencement of sales of the securities issued in this offering in compliance with FINRA Rule 5110(g)(8)(C). The piggyback registration rights provided will not be greater than seven years from the commencement of sales of the securities issued in this offering in compliance with FINRA Rule 5110(g)(8)(D). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the Representative’s Warrants may be adjusted in certain circumstances including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the Representative’s Warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.

SEC lock-up paragraph; source 1842579:1844530; SHA256 9ff5cc592c7480484783e3ec9c286222ed6a00f74b6e0e9a5fd9f6dd2cf2fe51 ↗
our executive officers and directors and holders of all of our common stock

Pursuant to “lock-up” agreements, we, and our executive officers and directors and holders of all of our common stock, have agreed, without the prior written consent of the Representative, not to, directly or indirectly, offer to sell, sell, pledge, or otherwise transfer or dispose of any of shares of (or enter into any transaction or device that is designed to, or could be expected to, result in the transfer or disposition by any person at any time in the future of) our common stock, enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of our common stock, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible into or exercisable or exchangeable for shares of common stock or any other of our securities or publicly disclose the intention to do any of the foregoing, subject to customary exceptions, for a period of 180 days from the closing date of this offering.

SEC lock-up paragraph; source 1845027:1846270; SHA256 d07068e929e05af3d33d1618ec24f0c6ba48512d44dc1f6bc5599d3e0f7f87ef ↗

Financial quality

Financial quality
CalculationReported value
Cash and cash equivalents2026-06-30 · Consolidated · Unaudited$4,826,000
Cash and cash equivalents2025-12-31 · Consolidated · Unaudited$1,846,000
Current assets2026-06-30 · Consolidated · Unaudited$22,342,000
Current assets2025-12-31 · Consolidated · Unaudited$18,874,000
Total assets2026-06-30 · Consolidated · Unaudited$56,494,000
Total assets2025-12-31 · Consolidated · Unaudited$52,974,000
Current liabilities2026-06-30 · Consolidated · Unaudited$35,146,000
Current liabilities2025-12-31 · Consolidated · Unaudited$30,441,000
Total liabilities2026-06-30 · Consolidated · Unaudited$66,247,000
Total liabilities2025-12-31 · Consolidated · Unaudited$62,593,000
Total equity / (deficit)2026-06-30 · Consolidated · Unaudited($9,753,000)
Total equity / (deficit)2025-12-31 · Consolidated · Unaudited($9,619,000)
General and administrative expenses6M ended 2026-06-30 · Consolidated · Unaudited$5,831,000
General and administrative expenses6M ended 2025-06-30 · Consolidated · Unaudited$5,792,000
Operating cash flow6M ended 2026-06-30 · Consolidated · Unaudited$5,039,000
Operating cash flow6M ended 2025-06-30 · Consolidated · Unaudited$406,000
Cash and cash equivalents2025-12-31 · Consolidated$1,846,000
Cash and cash equivalents2024-12-31 · Consolidated · Restated$958,000
Current assets2025-12-31 · Consolidated$18,874,000
Current assets2024-12-31 · Consolidated · Restated$15,038,000
Total assets2025-12-31 · Consolidated$52,974,000
Total assets2024-12-31 · Consolidated · Restated$44,389,000
Current liabilities2025-12-31 · Consolidated$30,441,000
Current liabilities2024-12-31 · Consolidated · Restated$19,123,000
Total liabilities2025-12-31 · Consolidated$62,593,000
Total liabilities2024-12-31 · Consolidated · Restated$52,186,000
Total equity / (deficit)2025-12-31 · Consolidated($9,619,000)
Total equity / (deficit)2024-12-31 · Consolidated · Restated($7,797,000)
General and administrative expensesFY2025 · Consolidated$11,385,000
General and administrative expensesFY2024 · Consolidated · Restated$11,774,000
Operating cash flowFY2025 · Consolidated($542)
Operating cash flowFY2024 · Consolidated · Restated$4,434
Basis and evidence
Cash and cash equivalents
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Cash and cash equivalents
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total current assets
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total current assets
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
TOTAL ASSETS
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
TOTAL ASSETS
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total current liabilities
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total current liabilities
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
TOTAL LIABILITIES
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
TOTAL LIABILITIES
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)
June 30, 2026; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)
December 31, 2025; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
General and administrative
6M ended 2026-06-30; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2026-06-30
General and administrative
6M ended 2025-06-30; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2025-06-30
Net cash provided by operating activities
6M ended 2026-06-30; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2026-06-30
Net cash provided by operating activities
6M ended 2025-06-30; consolidated unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2025-06-30
Cash and cash equivalents
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Cash and cash equivalents
December 31, 2024; consolidated restated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
Total current assets
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total current assets
December 31, 2024; consolidated restated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
TOTAL ASSETS
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
TOTAL ASSETS
December 31, 2024; consolidated restated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
Total current liabilities
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total current liabilities
December 31, 2024; consolidated restated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
TOTAL LIABILITIES
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
TOTAL LIABILITIES
December 31, 2024; consolidated restated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)
December 31, 2025; consolidated; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)
December 31, 2024; consolidated restated; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
General and administrative
FY2025; consolidated; currency symbol as printed ($); ISO currency not assigned; year ended 2025-12-31
General and administrative
FY2024; consolidated restated; currency symbol as printed ($); ISO currency not assigned; year ended 2024-12-31
Net cash used in operating activities
FY2025; consolidated; currency symbol as printed ($); ISO currency not assigned; year ended 2025-12-31
Net cash used in operating activities
FY2024; consolidated restated; currency symbol as printed ($); ISO currency not assigned; year ended 2024-12-31
Financial quality and runway
Financial review

Financial quality and runway

The latest supplied period is the six months ended June 30, 2026; interim results are unaudited and not necessarily indicative of the full year.

Cash and cash equivalents$4,826,000
Cash and cash equivalents$1,846,000
Total current assets$22,342,000
EvidenceFinancial review 1

Six-month 2026 net product sales were $29.318 million and net income was $0.071 million, versus $24.224 million sales and $0.032 million loss in the comparable 2025 period.

EvidenceFinancial review 2

Six-month 2026 operating cash flow was $5.039 million.

EvidenceFinancial review 3

For 2025, revenue was $49.170 million and net loss was $1.241 million; operating cash flow was negative $0.542 million.

EvidenceFinancial review 4

The filing states substantial indebtedness, working-capital deficit and a going-concern reference; the latest interim cash and debt balances are not supplied.

LATEST COMPARISON

Baseline filing — comparison pending

No source-comparable material changes identified in this report.

Open S-1 ↗

No source-comparable material changes identified in this report.

IPO177 explains the investment effect; the SEC source remains the authoritative record. Page-level locators are shown only when extracted and verified.

Loading filing history…

Risk 1

Failure to obtain or maintain CE-MDR, FDA 510(k), PMA or other approvals could delay or prevent commercialization.

Risk 2

Commercialization depends on reimbursement, healthcare-professional relationships, sales-force development and distributors.

Risk 3

The company reports operating losses, negative operating cash flow, substantial indebtedness, working-capital deficit and a going-concern reference.

Risk 4

Turzi's continuing control may limit minority investors' ability to influence transactions, including a change of control.

DocumentS-10001829126-26-010431
Filed2026-09-25SEC EDGAR
Research updated2026-09-26Analysed
Source-bound table inputs38SEC EDGAR
Open filing ↗